Fig. 1
From: Bafilomycin A1 inhibits SARS-CoV-2 infection in a human lung xenograft mouse model
Baf-A1 inhibits SARS-CoV-2 replication in Vero E6 cells. Cells were infected with SARS-CoV-2 (0.008 MOI), Beta variant (0.008 MOI) or Delta variant (0.008 MOI) before treatment with different doses of Baf-A1. A Viral load in the infected Vero E6 cells. B RT-qPCR analysis of N gene copies after virus infection and treatment with different doses of Baf-A1. C RT-qPCR analysis of E gene copies after viral infection and treatment with different doses of Baf-A1. Three experiments were performed (n = 5 each group). ***p < 0.001